Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- First Diality Patient Dialysis on New FDA-approved Moda-flx HD Machine Posted 01-13-2025
- Baxter will Provide a Supply Update in Early 2025 Posted 01-13-2025
- Baxter Plant Expected to be at 100% by the End of the Year Posted 12-11-2024
- PD patient and restaurant owner in Wichita worries about Baxter’s PD fluid shortage Posted 11-21-2024